Category

HIV/AIDS

HIV Vaccines Could Vastly Improve HIV Prevention – And You Can Help

By | Fenway Health Newsroom, HIV/AIDS, HIV/AIDS, The Fenway Institute | No Comments
There were a reported 2.1 million new HIV infections in 2015, and 36.7 million people are currently living with HIV/AIDS globally. Vaccines could be an incredibly powerful tool in the fight against HIV/AIDS, with the potential to dramatically reduce the number of new HIV infections around the world. In continuation of Fenway Health’s decades-long commitment to treating and preventing HIV/AIDS, The Fenway Institute is excited to serve as a study site for several HIV vaccine trials, including HVTN 108. HVTN 108 will examine both tolerability of a new HIV vaccine and the immune system’s response to it. It’s important to 
Read More

Policy Changes May Expand Behavioral Health Care Access For People Living With HIV/AIDS

By | Behavioral Health, Fenway Health Newsroom, Health Policy, HIV/AIDS, HIV/AIDS, The Fenway Institute | No Comments
Comprehensive behavioral health care is a key component of overall wellness. For people living with HIV (PLWH), access to these services is especially critical. The stress caused by pervasive stigma and discrimination around HIV/AIDS has been shown to contribute to a number of behavioral health problems, including depression, anxiety, psychological trauma, and substance abuse. The duel challenges of HIV and psychiatric diagnoses means that this population has unique behavioral health needs that must be integrated into culturally-competent care plans. A new brief from The National Center for Innovation in HIV Care at The Fenway Institute outlines recent changes in federal 
Read More

Help Shape The Future Of HIV Prevention: Join A Research Study Today

By | HIV/AIDS, HIV/AIDS, Research, The Fenway Institute | No Comments
The battle against HIV/AIDS has shifted dramatically in the past decade, as our understanding of the virus and how to combat it has increased. The introduction of Pre-Exposure Prophylaxis (PrEP), a daily pill commonly known as Truvada, has been an incredible game changer for HIV prevention. Currently, condom use and PrEP are the most proven effective methods for protection against HIV infection. “Using Truvada for PrEP has been revolutionary for HIV prevention, but, unfortunately, it’s not a one size fits all solution,” said Ryan Tappin, Clinical Manager, Biomedical Research at The Fenway Institute. “The more choices for PrEP that patients 
Read More

The Fenway Institute, Harlem United Launch Online LGBT, HIV, and Health Equity Voting Resource for Voters

By | Fenway Health Newsroom, Health Policy, HIV/AIDS, HIV/AIDS, LGBT Health, News, The Fenway Institute | No Comments
With less than a month left before Election Day, Harlem United and Fenway Health have launched a campaign to educate voters about where the presidential candidates and the political parties stand on six key health equity issues: LGBT equality; HIV/AIDS; healthcare ; substance use; mental health; and housing. Past and current positions on health equity issues were compiled from official campaign statements, party platforms, interviews and articles, and records as public servants or public figures. The campaign consists of social media, a website, and an in-depth report on the candidates and party platforms. “There are some striking―and surprising―differences among the 
Read More

Study Examines Global HIV Transmission Trends

By | Fenway Health Newsroom, HIV/AIDS, HIV/AIDS, The Fenway Institute | No Comments
Treatment as prevention (TasP) is a powerful tool in the international effort to end HIV transmissions. A new paper titled “Frequency and predictors of estimated HIV transmissions and bacterial STI acquisition among HIV-positive patients in HIV care across three continents” outlines the findings from the HPTN063 study, which estimated the frequency and predictors of numbers of HIV transmissions and bacterial sexually transmitted infection (STI) acquisition among sexually active HIV-positive individuals in care from three representative global settings. Dr. Steven Safren, Affiliated Investigator at Fenway Health and Professor of Psychology at University of Miami, served as the HPTN063 study Chair and 
Read More